Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Value Type description Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 501 to 550 of 33156 in total 
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Value Type\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
core1 udp-galactose:n-acetylgalactosamine-alpha-r beta 1,3-galac. [source:refseq;acc:nm\_020156]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
73677.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57498.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28138\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
43.4554\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
31.7576\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.36835\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
t-box transcription factor tbx19 (t-box protein 19). [source:swissprot;acc:o60806]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
61.4851\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
68.1264\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10801\vspace{3pt}}\\\hline
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.868\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.159\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25965\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor jun-d. [source:swissprot;acc:p17535]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.709\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.361\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10552\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
neurochondrin. [source:refseq;acc:nm\_014284]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
73677.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57498.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.28138\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
rab11-family interacting protein 4. [source:refseq;acc:nm\_032932]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
73.6221\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
81.4944\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10693\vspace{3pt}}\\\hline
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13005.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14773.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.13593\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.136\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.077\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25807\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.728\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.388\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10546\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
septin-like protein kiaa0202 (fragment). [source:swissprot;acc:q92599]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
75490.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
95493.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.26497\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
eferin. [source:swissprot;acc:o75154]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
73.6221\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
81.4944\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10693\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4900.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5555.81\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.13368\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.136\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.077\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25807\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial tumor suppressor gene 1; transcription factor mtsg1; at2 receptor-interacting protein 1; erythroid differentiation-related gene. [source:refseq;acc:nm\_020749]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.902\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.783\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10518\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
septin 10 isoform 1. [source:refseq;acc:nm\_144710]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
74803.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
94281\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.26038\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
55.8923\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
61.8016\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10573\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12176.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13781.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.1318\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
165.535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
149.799\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10505\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
74378.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
93531.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25751\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
brachyury protein (t protein). [source:swissprot;acc:o15178]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
61.687\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
68.2003\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10559\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
19498.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17265.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.12932\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
239.692\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
217.005\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10455\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
27909.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
35068.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25653\vspace{3pt}}\\\cline{2-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
55.9786\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
61.8641\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10514\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{6}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
amino acid transporter xat2; likely ortholog of mouse aspartate/glutamate transporter 1 (agt1). [source:refseq;acc:nm\_138817]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
testis-specific protein tex28. [source:swissprot;acc:o15482]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
259.517\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
235.017\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.10425\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
Squared\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial precursor (ec 1.5.1.12) (p5c dehydrogenase). [source:swissprot;acc:p30038]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
80538.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
64191.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.25465\vspace{3pt}}\\\cline{3-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/